Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan

This publication has 21 references indexed in Scilit:

• Surveillance of Hospital-Acquired Central Line–Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients Lessons Learned, Challenges Ahead
  Infection Control & Hospital Epidemiology, 2013
• CLABSI Rates in Immunocompromised Patients: A Valuable Patient Centered Outcome?
  Clinical Infectious Diseases, 2011
• Guidelines for the prevention of intravascular catheter-related infections
  American Journal of Infection Control, 2011
• Intestinal Damage Determines the Inflammatory Response and Early Complications in Patients Receiving Conditioning for a Stem Cell Transplantation
  PLOS ONE, 2010
• Current Definitions of Central Line–Associated Bloodstream Infection Is the Emperor Wearing Clothes?
  Infection Control & Hospital Epidemiology, 2010
• Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality
  Bone Marrow Transplantation, 2007
• Catheter‐related bloodstream infections in hematology
  Cancer, 2007
• Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital*
  Critical Care Medicine, 2006
• Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview
  Bone Marrow Transplantation, 2000
• Bacterial Translocation and Gram-Negative Bacteremia in Patients with Hematological Malignancies
  The Journal of Infectious Diseases, 1985